Evome Medical Technologies (TSXV:EVMT) ROCE % : -301.55% (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Evome Medical Technologies ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Evome Medical Technologies's annualized ROCE % for the quarter that ended in Dec. 2023 was -301.55%.

Evome Medical Technologies ROCE % Historical Data

The historical data trend for Evome Medical Technologies's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evome Medical Technologies ROCE % Chart

Evome Medical Technologies Annual Data

Trend

Dec14

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Dec23

ROCE %

Get a 7-Day Free Trial

-19.70

-12.66

-50.64

-31.23

-85.43

Evome Medical Technologies Quarterly Data
	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															-22.69	-23.58	-11.76	55.80	-301.55

Evome Medical Technologies ROCE % Calculation

Evome Medical Technologies's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Feb. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Feb. 2022 )		(A: Dec. 2023 )
	=	-12.906	/	( ( (42.682 - 23.156)	+	(48.257 - 37.57) )	/ 2 )
	=	-12.906	/	( (19.526	+	10.687)	/ 2 )
	=	-12.906	/	15.1065
	=	-85.43 %

Evome Medical Technologies's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-58.152	/	( ( (67.892 - 40.01)	+	(48.257 - 37.57) )	/ 2 )
	=	-58.152	/	( ( 27.882	+	10.687 )	/ 2 )
	=	-58.152	/	19.2845
	=	-301.55 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Evome Medical Technologies (TSXV:EVMT) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Evome Medical Technologies ROCE % Related Terms

Thank you for viewing the detailed overview of Evome Medical Technologies's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Evome Medical Technologies (TSXV:EVMT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Evome Medical Technologies Inc (TSXV:EVMT) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

LNDZF:USA

Address

6160 Innovation Way, Carlsbad, CA, USA, 92009

Website

https://www.salonaglobal.com

Evome Medical Technologies Inc is a medical device company. It is focused on human performance and rehabilitative solutions.